RTX stock swings after Trump calls for $1.5 trillion military budget, targets buybacks

RTX stock swings after Trump calls for $1.5 trillion military budget, targets buybacks

NEW YORK, Jan 8, 2026, 13:10 EST — Regular session

RTX Corp (RTX.N) shares rose 1.3% to $188.09 in afternoon trading on Thursday, after earlier touching $197.00. The stock has seesawed as President Donald Trump pressed for a bigger Pentagon budget while warning defense contractors over dividends and buybacks.

Trump said on Wednesday the 2027 U.S. military budget should be $1.5 trillion, well above the $901 billion approved for 2026, sparking a fresh bid for defense names in early trade. Northrop Grumman jumped 8.3% and Lockheed Martin rose 6.4%, while RTX climbed 3.7% and General Dynamics gained 3%, the report said. RBC Capital Markets analysts led by Ken Herbert said the budget push could “offset the negative investor sentiment” from tighter limits on cash returns, but flagged uncertainty around the final spending bill; Morgan Stanley’s Kristine Liwag called the hit to payouts “incremental” and “manageable.” 1

That optimism sits alongside a harder line from the White House. Trump’s executive order bars major defense contractors from paying dividends — regular cash payouts — or buying back stock, where a company repurchases its own shares, until they deliver weapons “on time and on budget.” The order gives Defense Secretary Pete Hegseth 30 days to identify underperforming firms and directs the SEC to consider regulations to implement the proposed ban. 2

Trump also singled out RTX’s Raytheon unit in a social media post, calling it the “least responsive” to Pentagon needs. He warned the company would not be allowed “any additional Stock Buybacks” if it wants more U.S. government business and threatened to cut contracts. 3

Wall Street was mixed as big tech weighed on the Nasdaq, but defense shares held the spotlight. “The defense budget is growing, if anything … investors don’t seem to care,” said Joe Saluzzi, partner and co-founder at Themis Trading. 4

But the policy whiplash cuts both ways. If the administration turns its order into enforceable contract language, big primes could face tougher cash-return limits and a higher bar on delivery performance, and any pullback in the budget push would take air out of the trade.

RTX also pointed shareholders to a separate issue this week. The company said an unsolicited “mini-tender” offer from Tutanota LLC seeks to buy up to 500,000 shares at $130 each and urged investors not to tender, warning the bid is below market and comes with conditions; mini-tenders typically cover less than 5% of shares and avoid many SEC tender-offer rules. 5

Next up is RTX’s own read on demand and cash plans. RTX said it will report fourth-quarter and full-year 2025 results on Jan. 27 before the market opens, with a conference call at 8:30 a.m. ET, setting up the next test for guidance and capital return plans under Washington’s new glare. 6

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
IREN stock jumps 6% in Nasdaq trade as bitcoin miners rebound; CES buzz and payrolls ahead
Previous Story

IREN stock jumps 6% in Nasdaq trade as bitcoin miners rebound; CES buzz and payrolls ahead

VNET stock jumps nearly 10% as 21Vianet rides a China tech bid — what traders watch next
Next Story

VNET stock jumps nearly 10% as 21Vianet rides a China tech bid — what traders watch next

Go toTop